[1] Collaborators GBD 2017 Cirrhosis. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol, 2020, 5(3): 245-266. [2] Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol, 2019, 71(1): 212-221. [3] Wang X, Lin SX, Tao J, et al. Study of liver cirrhosis over ten consecutive years in Southern China. World J Gastroenterol, 2014, 20(37): 13546-13555. [4] Man S, Deng Y, Ma Y, et al. Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China. Gastroenterology, 2023, 165(4): 1025-1040. [5] Wu Z, Wang W, Zhang K, et al. Trends in the incidence of cirrhosis in global from 1990 to 2019: a join point and age-period-cohort analysis. J Med Virol, 2023, 95(6): e28858. [6] 唐承薇. 肝硬化//葛均波, 徐永健. 内科学(第八版). 北京; 人民卫生出版社, 2013: 419-428. [7] Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis-a etiology, trends and predictions. Nat Rev Gastroenterol Hepatol, 2023, 20(6): 388-398. [8] Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol, 2019, 71(1): 212-221. [9] Wang X, Lin SX, Tao J, et al. Study of liver cirrhosis over ten consecutive years in southern China. World J Gastroenterol, 2014, 20(37): 13546-13555. [10] Li M, Wang ZQ, Zhang L, et al. Burden of cirrhosis and other chronic liver diseases caused by specific etiologies in China, 1990-2016: findings from the global burden of disease study 2016. Biomed Environ Sci, 2020, 33(1): 1-10. [11] 中华医学会消化病学分会. 中国肝硬化临床诊治共识意见. 中华消化杂志, 2023, (4): 227-247. [12] Shi C, Shi H, Chen C, et al. Trends of hospitalisation for patients with liver cirrhosis in Ningxia, China: a cross-sectional study. BMJ Open, 2023, 13(8): e068655. [13] Kotsiliti E. Liver steatosis and fibrosis in China. Nat Rev Gastroenterol Hepatol, 2023, 20(10): 631. [14] Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol, 2023, 20(8): 524-537. [15] Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol, 2020, 5(2): 167-228. [16] Wang H, Men P, Xiao Y, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis, 2019, 19(1): 811. [17] Ye X, Li T, Li Y, et al. Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China. Transfus Med, 2023, 33(1): 81-89. [18] Zhu B, Zhou J, Chen Y, et al. Incidence rate, risk factors and behaviour changes for alcohol drinking: findings from a community-based cohort study in southwest China. BMJ Open, 2022, 12(9): e060914. [19] Ginès P, Krag A, Abraldes JG, et al. Liver cirrhosis. Lancet, 2021, 398(10308): 1359-1376. [20] 南月敏, 李佳峥. 肝硬化与感染. 实用肝脏病杂志, 2022, 25(5): 609-611. |